Notable Analyst Upgrades and Downgrades for Week of May 2 2022

 

Upgrades 

 

Arthur J. Gallagher & Co. (NYSE:AJG) was upgraded by research analysts at Raymond James from an “outperform” rating to a “strong-buy” rating in a research report issued to clients and investors on Monday, The Fly reports. 

Other equities analysts have also recently issued research reports about the company. UBS Group started coverage on Arthur J. Gallagher & Co. in a report on Monday, April 18th. They issued a “neutral” rating and a $192.00 target price for the company. William Blair reiterated an “outperform” rating on shares of Arthur J. Gallagher & Co. in a research report on Thursday, January 27th. Wells Fargo & Company upped their price target on Arthur J. Gallagher & Co. from $193.00 to $209.00 and gave the company an “overweight” rating in a research report on Tuesday, April 12th. Royal Bank of Canada cut their target price on Arthur J. Gallagher & Co. from $170.00 to $160.00 in a research report on Friday, January 28th. Finally, Zacks Investment Research upgraded Arthur J. Gallagher & Co. from a “hold” rating to a “strong-buy” rating and set a $191.00 price target on the stock in a report on Friday, March 25th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating, seven have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, Arthur J. Gallagher & Co. currently has an average rating of “Buy” and a consensus price target of $173.59. Read more ... 

 

JPMorgan Chase & Co. upgraded shares of SJW Group (NYSE:SJW) from a neutral rating to an overweight rating in a report published on Monday morning, The Fly reports. The firm currently has $67.00 price objective on the utilities provider’s stock. 

A number of other equities research analysts have also recently commented on the company. StockNews.com initiated coverage on SJW Group in a report on Thursday, March 31st. They set a hold rating on the stock. Barclays increased their target price on SJW Group from $70.00 to $73.00 and gave the company an equal weight rating in a report on Tuesday, March 15th. Zacks Investment Research cut SJW Group from a hold rating to a sell rating in a report on Wednesday, March 30th. Finally, Seaport Res Ptn upgraded SJW Group from a neutral rating to a buy rating in a report on Tuesday, January 25th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the stock. According to MarketBeat, the stock has an average rating of Hold and a consensus target price of $72.50. Read more ... 

 

JPMorgan Chase & Co. (NYSE:JPM) was upgraded by investment analysts at Oppenheimer from a “market perform” rating to an “outperform” rating in a report released on Tuesday, The Fly reports. 

A number of other research analysts also recently weighed in on the stock. Zacks Investment Research upgraded shares of JPMorgan Chase & Co. from a “sell” rating to a “hold” rating and set a $147.00 price target on the stock in a report on Monday, March 21st. Morgan Stanley reduced their price target on JPMorgan Chase & Co. from $170.00 to $161.00 and set an “underweight” rating for the company in a research report on Monday, March 28th. Barclays set a $200.00 price target on JPMorgan Chase & Co. in a research note on Wednesday, April 6th. Argus decreased their price target on JPMorgan Chase & Co. from $177.00 to $155.00 in a research note on Thursday, April 14th. Finally, Keefe, Bruyette & Woods decreased their price target on JPMorgan Chase & Co. from $166.00 to $157.00 and set a “market perform” rating for the company in a research note on Monday, January 17th. One investment analyst has rated the stock with a sell rating, eleven have assigned a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $163.72. Read more ... 

 

 

Linde (NYSE:LIN) was upgraded by equities researchers at AlphaValue to a "reduce" rating in a report issued on Tuesday, The Fly reports. 

Other equities analysts also recently issued research reports about the stock. BMO Capital Markets cut their price target on shares of Linde from $405.00 to $365.00 and set an "outperform" rating on the stock in a report on Monday, February 14th. Citigroup increased their price target on shares of Linde from $381.00 to $400.00 in a report on Tuesday, January 11th. Jefferies Financial Group started coverage on shares of Linde in a research note on Wednesday, March 30th. They set a "buy" rating and a $390.00 price objective on the stock. Morgan Stanley raised their price objective on shares of Linde from $330.00 to $365.00 and gave the stock an "overweight" rating in a research note on Tuesday, January 11th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and set a $352.00 price objective on shares of Linde in a research note on Friday. One research analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have issued a buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Buy" and a consensus target price of $360.47. Read more ... 

 

Morgan Stanley (NYSE:MS) was upgraded by Oppenheimer from a “market perform” rating to an “outperform” rating in a research report issued on Tuesday, The Fly reports. 

MS has been the subject of a number of other research reports. UBS Group raised their target price on shares of Morgan Stanley from $119.00 to $125.00 and gave the company a “buy” rating in a research report on Tuesday, January 4th. BMO Capital Markets raised their target price on shares of Morgan Stanley from $110.00 to $113.00 and gave the company an “outperform” rating in a research report on Monday, April 18th. The Goldman Sachs Group set a $105.00 price target on shares of Morgan Stanley in a research note on Wednesday, April 20th. Wells Fargo & Company cut their price target on shares of Morgan Stanley from $104.00 to $94.00 and set an “equal weight” rating for the company in a research note on Monday, April 4th. Finally, Zacks Investment Research cut shares of Morgan Stanley from a “buy” rating to a “hold” rating and set a $91.00 price target for the company. in a research note on Wednesday, March 16th. Twelve analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $106.71. Read more ... 

 

Starbucks (NASDAQ:SBUX) was upgraded by investment analysts at Evercore ISI from an “in-line” rating to an “outperform” rating in a research report issued to clients and investors on Wednesday, The Fly reports. The brokerage presently has a $95.00 target price on the coffee company’s stock. Evercore ISI’s target price would indicate a potential upside of 22.61% from the company’s previous close. 

SBUX has been the subject of several other reports. UBS Group lowered their price objective on Starbucks from $105.00 to $86.00 and set a “neutral” rating for the company in a research report on Monday, April 25th. The Goldman Sachs Group cut Starbucks from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $112.00 to $106.00 in a research note on Wednesday, February 2nd. Citigroup cut Starbucks from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $120.00 to $91.00 in a research note on Monday, April 11th. MKM Partners cut their price target on Starbucks from $115.00 to $105.00 and set a “buy” rating on the stock in a research note on Wednesday, April 20th. Finally, Robert W. Baird cut their price target on Starbucks from $95.00 to $85.00 in a research note on Monday, April 25th. One analyst has rated the stock with a sell rating, thirteen have given a hold rating and fourteen have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $102.46. Read more ... 

 

 

Scotts Miracle-Gro (NYSE:SMG) was upgraded by research analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a report released on Wednesday, The Fly reports. The analysts noted that the move was a valuation call. 

Other research analysts also recently issued research reports about the company. Barclays downgraded Scotts Miracle-Gro from an “overweight” rating to an “equal weight” rating and lowered their target price for the company from $150.00 to $110.00 in a report on Thursday, April 21st. Wells Fargo & Company reduced their price target on Scotts Miracle-Gro from $170.00 to $160.00 and set an “overweight” rating for the company in a research report on Thursday, March 17th. Truist Financial reduced their price target on Scotts Miracle-Gro from $225.00 to $185.00 in a research report on Tuesday, March 22nd. Zacks Investment Research upgraded Scotts Miracle-Gro from a “sell” rating to a “hold” rating and set a $123.00 price target for the company in a research report on Tuesday, April 12th. Finally, Raymond James reduced their price target on Scotts Miracle-Gro from $185.00 to $150.00 and set a “strong-buy” rating for the company in a research report on Monday, March 14th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $180.89. Read more ... 

 

 

Downgrades 

 

KeyCorp (NYSE:KEY) was downgraded by equities research analysts at Piper Sandler from a “neutral” rating to an “underweight” rating in a research report issued on Monday, MarketBeat reports. They presently have a $20.50 price objective on the financial services provider’s stock, down from their previous price objective of $23.00. Piper Sandler’s price objective would suggest a potential upside of 4.01% from the company’s previous close. 

A number of other research firms have also recently issued reports on KEY. Odeon Capital Group cut KeyCorp from a “buy” rating to a “hold” rating in a report on Tuesday, April 26th. Citigroup reiterated a “neutral” rating on shares of KeyCorp in a report on Thursday, March 24th. Jefferies Financial Group cut KeyCorp from a “buy” rating to a “hold” rating in a report on Monday, April 11th. Morgan Stanley cut their price objective on KeyCorp from $30.00 to $27.00 and set an “equal weight” rating for the company in a report on Monday, March 28th. Finally, Barclays upped their price objective on KeyCorp from $24.00 to $26.00 in a report on Monday, January 3rd. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Buy” and an average target price of $26.83. Read more ... 

  

Amgen (NASDAQ:AMGN) was downgraded by research analysts at Oppenheimer to an “outperform” rating in a report released on Tuesday. They currently have a $285.00 target price on the medical research company’s stock. Oppenheimer’s target price would indicate a potential upside of 20.71% from the stock’s previous close. Oppenheimer also issued estimates for Amgen’s FY2022 earnings at $17.12 EPS, FY2023 earnings at $18.92 EPS, FY2024 earnings at $21.17 EPS, FY2025 earnings at $23.40 EPS and FY2026 earnings at $25.84 EPS. 

Several other research analysts have also issued reports on the stock. Jefferies Financial Group lifted their price target on shares of Amgen from $266.00 to $280.00 and gave the stock a “buy” rating in a research report on Wednesday, February 9th. Wells Fargo & Company raised their price objective on shares of Amgen from $210.00 to $250.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 9th. Barclays raised their price objective on shares of Amgen from $233.00 to $236.00 and gave the stock an “equal weight” rating in a research note on Tuesday, April 12th. TheStreet lowered shares of Amgen from a “b+” rating to a “c+” rating in a research note on Wednesday, April 27th. Finally, StockNews.com lowered shares of Amgen from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, April 5th. One analyst has rated the stock with a sell rating, eleven have given a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $240.00. Read more ... 

 

 

Algonquin Power & Utilities (TSE:AQN) was downgraded by investment analysts at National Bank Financial from an "outperfrom under weight" rating to a "sector perform under weight" rating in a report issued on Tuesday. National Bank Financial also issued estimates for Algonquin Power & Utilities' Q1 2022 earnings at $0.27 EPS, Q4 2022 earnings at $0.26 EPS and FY2023 earnings at $0.95 EPS. 

AQN has been the subject of a number of other reports. Royal Bank of Canada restated an "outperform" rating and issued a C$18.00 target price on shares of Algonquin Power & Utilities in a research note on Tuesday, January 4th. National Bankshares downgraded Algonquin Power & Utilities to a "hold" rating in a research report on Wednesday. Four research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Buy" and an average price target of C$20.00. Read more ... 

 

Atlantic Securities downgraded shares of Colgate-Palmolive (NYSE:CL) from an overweight rating to a neutral rating in a report published on Tuesday, Marketbeat Ratings reports. The firm currently has $80.00 price objective on the stock, down from their prior price objective of $92.00. 

A number of other equities research analysts also recently issued reports on CL. TheStreet upgraded shares of Colgate-Palmolive from a c+ rating to a b rating in a research note on Friday, April 29th. StockNews.com downgraded shares of Colgate-Palmolive from a buy rating to a hold rating in a research note on Wednesday, April 13th. Stifel Nicolaus reduced their price target on shares of Colgate-Palmolive from $90.00 to $88.00 in a research note on Wednesday, April 13th. JPMorgan Chase & Co. reduced their price target on shares of Colgate-Palmolive from $86.00 to $81.00 and set a neutral rating on the stock in a research note on Wednesday, March 30th. Finally, Wells Fargo & Company reduced their price target on shares of Colgate-Palmolive from $78.00 to $76.00 and set an underweight rating on the stock in a research note on Monday, January 31st. Two investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of Hold and a consensus target price of $85.56. Read more ... 

  

Consolidated Edison (NYSE:ED) was downgraded by equities research analysts at Wells Fargo & Company from an "equal weight" rating to a "sell" rating in a research note issued to investors on Tuesday, MarketBeat.com reports. They presently have a $94.00 price objective on the utilities provider's stock, up from their previous price objective of $85.00. Wells Fargo & Company's price objective would indicate a potential upside of 2.16% from the stock's previous close. 

Several other equities research analysts also recently issued reports on the stock. Guggenheim downgraded shares of Consolidated Edison from a "neutral" rating to a "sell" rating and cut their price objective for the stock from $77.00 to $71.00 in a research report on Thursday, January 20th. Morgan Stanley raised their price objective on shares of Consolidated Edison from $75.00 to $82.00 and gave the stock an "underweight" rating in a research report on Wednesday, April 20th. Wolfe Research upgraded shares of Consolidated Edison from an "underperform" rating to a "peer perform" rating and set a $82.00 price target for the company in a research report on Thursday, February 17th. KeyCorp lifted their price target on shares of Consolidated Edison from $71.00 to $72.00 and gave the company an "underweight" rating in a research report on Wednesday, April 20th. Finally, The Goldman Sachs Group lifted their price target on shares of Consolidated Edison from $65.00 to $83.00 and gave the company a "sell" rating in a research report on Thursday, March 31st. Seven equities research analysts have rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $82.83. Read more ... 

 

 

Kellogg (NYSE:K) was downgraded by research analysts at Piper Sandler from a "neutral" rating to an "underweight" rating in a report issued on Tuesday, Briefing.com reports. They currently have a $62.00 target price on the stock, down from their prior target price of $66.00. Piper Sandler's price target suggests a potential downside of 7.97% from the company's current price. 

Several other research firms have also issued reports on K. StockNews.com initiated coverage on Kellogg in a research note on Thursday, March 31st. They set a "hold" rating on the stock. BMO Capital Markets lowered shares of Kellogg from an "outperform" rating to a "market perform" rating and lowered their price objective for the company from $75.00 to $70.00 in a research note on Monday, January 31st. Deutsche Bank Aktiengesellschaft downgraded shares of Kellogg from a "buy" rating to a "hold" rating and cut their target price for the stock from $74.00 to $73.00 in a research note on Monday, April 25th. Bank of America downgraded shares of Kellogg from a "buy" rating to a "neutral" rating and dropped their price target for the stock from $76.00 to $70.00 in a research note on Wednesday, January 5th. Finally, UBS Group assumed coverage on Kellogg in a research report on Wednesday, March 30th. They set a "buy" rating and a $73.00 price objective on the stock. Two investment analysts have rated the stock with a sell rating, nine have given a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $66.80. Read more ... 

 

Piper Sandler cut shares of Tyson Foods (NYSE:TSN) from a neutral rating to an underweight rating in a research note published on Tuesday morning, Marketbeat Ratings reports. They currently have $81.00 price target on the stock, down from their previous price target of $87.00. 

TSN has been the topic of a number of other reports. Stephens boosted their target price on Tyson Foods from $110.00 to $115.00 and gave the stock an overweight rating in a research report on Tuesday, February 8th. JPMorgan Chase & Co. boosted their target price on Tyson Foods from $88.00 to $91.00 and gave the company a neutral rating in a research note on Tuesday, February 8th. Barclays downgraded Tyson Foods from an overweight rating to an equal weight rating and boosted their target price for the company from $95.00 to $100.00 in a research note on Monday, February 14th. StockNews.com upgraded Tyson Foods from a buy rating to a strong-buy rating in a research note on Friday, April 15th. Finally, Zacks Investment Research downgraded Tyson Foods from a buy rating to a hold rating and set a $98.00 target price on the stock. in a research note on Monday, April 11th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, Tyson Foods presently has a consensus rating of Hold and an average price target of $97.33. Read more ... 

 

Leggett & Platt (NYSE:LEG) was downgraded by equities research analysts at Raymond James from an "outperform" rating to a "market perform" rating in a note issued to investors on Wednesday, Briefing.com reports. 

Several other equities research analysts also recently issued reports on LEG. StockNews.com raised Leggett & Platt from a "sell" rating to a "hold" rating in a research note on Tuesday. Piper Sandler decreased their price target on shares of Leggett & Platt from $43.00 to $38.00 and set a "neutral" rating for the company in a report on Thursday, April 7th. Finally, TheStreet cut shares of Leggett & Platt from a "b-" rating to a "c+" rating in a report on Friday, March 11th. Three investment analysts have rated the stock with a hold rating and one has given a buy rating to the company's stock. According to MarketBeat, Leggett & Platt presently has an average rating of "Hold" and an average target price of $46.00. 

Shares of Leggett & Platt stock opened at $38.34 on Wednesday. The company's 50-day moving average price is $36.35 and its two-hundred day moving average price is $39.77. The stock has a market cap of $5.13 billion, a PE ratio of 12.95, a price-to-earnings-growth ratio of 1.32 and a beta of 1.30. The company has a current ratio of 1.55, a quick ratio of 0.80 and a debt-to-equity ratio of 1.09. Leggett & Platt has a 52 week low of $33.80 and a 52 week high of $59.16. Read more ... 

 

 

AbbVie (NYSE:ABBV) was downgraded by investment analysts at Daiwa Capital Markets from an "outperform" rating to a "neutral" rating in a report released on Friday, The Fly reports. 

ABBV has been the subject of a number of other research reports. Wells Fargo & Company lifted their price objective on shares of AbbVie from $165.00 to $200.00 in a research report on Monday. Bank of America lifted their price objective on shares of AbbVie from $135.00 to $138.00 and gave the company a "neutral" rating in a research report on Thursday, February 3rd. BMO Capital Markets lifted their price objective on shares of AbbVie from $161.00 to $174.00 and gave the company an "outperform" rating in a research report on Monday, April 25th. Mizuho lifted their target price on shares of AbbVie from $154.00 to $166.00 and gave the stock a "buy" rating in a report on Friday, February 4th. Finally, JPMorgan Chase & Co. lifted their target price on shares of AbbVie from $165.00 to $180.00 in a report on Thursday, February 3rd. Five equities research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Buy" and a consensus price target of $160.07. Read more ... 

 

Black Hills (NYSE:BKH - Get Rating) was downgraded by equities researchers at Mizuho from a "buy" rating to a "neutral" rating in a research note issued on Friday, The Fly reports. 

Separately, StockNews.com lowered Black Hills from a "hold" rating to a "sell" rating in a research report on Wednesday, April 27th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $75.00. 

BKH stock opened at $75.34 on Friday. The company has a current ratio of 0.90, a quick ratio of 0.73 and a debt-to-equity ratio of 1.43. Black Hills has a 12-month low of $61.95 and a 12-month high of $80.95. The stock has a market cap of $4.88 billion, a price-to-earnings ratio of 18.69, a PEG ratio of 2.89 and a beta of 0.48. The business's 50-day moving average is $74.71 and its 200 day moving average is $69.82. Read more ... 

 

Notable Analyst Upgrades and Downgrades for Week of February 28 2022

 

Upgrades:

 

American Electric Power (NASDAQ:AEP) was upgraded by investment analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating in a report released on Monday, Briefing.com reports. The brokerage currently has a $101.00 target price on the stock, up from their previous target price of $93.00. Wells Fargo & Company's target price points to a potential upside of 12.90% from the company's current price.

Separately, Morgan Stanley cut their target price on shares of American Electric Power from $110.00 to $105.00 and set an "overweight" rating on the stock in a research note on Friday, February 18th. Six analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company presently has an average rating of "Buy" and an average target price of $96.78.

Shares of NASDAQ AEP opened at $89.46 on Monday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.48 and a current ratio of 0.63. The firm has a market cap of $45.06 billion, a price-to-earnings ratio of 17.96, a PEG ratio of 3.08 and a beta of 0.35. American Electric Power has a 1 year low of $74.80 and a 1 year high of $91.66. The stock's 50-day simple moving average is $88.50 and its 200-day simple moving average is $86.41. Read more …

 

Lockheed Martin (NYSE:LMT) was upgraded by equities researchers at Wolfe Research from a “peer perform” rating to an “outperform” rating in a note issued to investors on Monday, Briefing.com reports.

Several other equities analysts also recently commented on LMT. Robert W. Baird increased their price objective on shares of Lockheed Martin from $376.00 to $425.00 in a research note on Wednesday, January 26th. Susquehanna raised their price target on shares of Lockheed Martin from $400.00 to $445.00 in a research note on Wednesday, January 26th. Bank of America downgraded shares of Lockheed Martin from a “buy” rating to a “neutral” rating and dropped their price target for the company from $440.00 to $375.00 in a research note on Monday, November 1st. Wells Fargo & Company increased their price objective on shares of Lockheed Martin from $379.00 to $400.00 and gave the stock an “equal weight” rating in a research report on Wednesday, January 26th. Finally, Sanford C. Bernstein increased their price objective on shares of Lockheed Martin from $387.00 to $401.00 in a research report on Wednesday, January 26th. Seven equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $410.68. Read more …

 

Kroger (NYSE:KR) was upgraded by investment analysts at Telsey Advisory Group from a “market perform” rating to an “outperform” rating in a research report issued to clients and investors on Tuesday, Briefing.com reports. The brokerage presently has a $54.00 price objective on the stock, up from their prior price objective of $47.00. Telsey Advisory Group’s target price points to a potential upside of 15.38% from the stock’s previous close.

A number of other research analysts have also recently weighed in on the stock. Wells Fargo & Company cut shares of Kroger from an “equal weight” rating to an “underweight” rating and set a $42.00 target price on the stock. in a research note on Tuesday, January 25th. JPMorgan Chase & Co. upped their price target on shares of Kroger from $44.00 to $45.00 in a research note on Friday. UBS Group upped their price target on shares of Kroger from $44.00 to $48.00 and gave the company a “neutral” rating in a research note on Friday, December 3rd. Bank of America upgraded shares of Kroger from an “underperform” rating to a “neutral” rating and upped their price target for the company from $38.00 to $52.00 in a research note on Wednesday, January 19th. Finally, Zacks Investment Research cut shares of Kroger from a “hold” rating to a “sell” rating and set a $47.00 price target on the stock. in a research note on Friday. Six analysts have rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $44.88. Read more …

 

 

Pembina Pipeline (NYSE:PBA  (TSE:PPL) was upgraded by stock analysts at BMO Capital Markets from a “market perform” rating to an “outperform” rating in a research note issued to investors on Tuesday, The Fly reports.

PBA has been the subject of several other research reports. TD Securities raised their target price on shares of Pembina Pipeline from C$44.00 to C$45.00 in a report on Monday. JPMorgan Chase & Co. started coverage on shares of Pembina Pipeline in a report on Tuesday, November 23rd. They set a “neutral” rating for the company. National Bank Financial raised their target price on shares of Pembina Pipeline from C$41.00 to C$42.00 in a report on Wednesday, January 26th. Zacks Investment Research raised shares of Pembina Pipeline from a “hold” rating to a “buy” rating and set a $34.00 target price for the company in a report on Wednesday, February 9th. Finally, Tudor Pickering reissued a “buy” rating and set a C$45.00 target price on shares of Pembina Pipeline in a report on Friday, November 5th. Six equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of $42.61. Read more …

 

Notable Analyst Upgrades and Downgrades for Week of November 22 2021

 

Upgrades:

 

Kimco Realty (NYSE:KIM) was upgraded by equities researchers at Evercore ISI to an "outperform" rating in a note issued to investors on Monday, The Fly reports.

KIM has been the topic of several other research reports. Capital One Financial raised Kimco Realty from an "equal weight" rating to an "overweight" rating and set a $26.00 target price on the stock in a research report on Monday, August 2nd. BTIG Research restated a "hold" rating on shares of Kimco Realty in a research note on Sunday, September 26th. Truist upped their price objective on Kimco Realty from $23.00 to $25.00 and gave the stock a "buy" rating in a research note on Monday, August 30th. Truist Securities upped their target price on Kimco Realty from $23.00 to $25.00 and gave the company a "buy" rating in a research report on Monday, August 30th. Finally, Morgan Stanley upped their target price on Kimco Realty from $25.00 to $26.00 and gave the company an "overweight" rating in a research report on Thursday, August 19th. Three research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Buy" and an average price target of $23.32.

KIM stock opened at $24.05 on Monday. Kimco Realty has a twelve month low of $14.03 and a twelve month high of $24.95. The stock has a market cap of $14.83 billion, a P/E ratio of 12.59, a PEG ratio of 2.11 and a beta of 1.50. The business's 50-day moving average price is $22.55 and its 200-day moving average price is $21.71. Read more …

 

Royal Gold (NASDAQ:RGLD) (TSE:RGL) was upgraded by research analysts at Bank of America from an "underperform" rating to a "neutral" rating in a report issued on Monday, The Fly reports.

RGLD has been the topic of a number of other research reports. TD Securities lowered their price objective on Royal Gold from $145.00 to $140.00 and set a "buy" rating on the stock in a report on Friday, August 13th. Zacks Investment Research raised Royal Gold from a "sell" rating to a "hold" rating and set a $106.00 price objective on the stock in a report on Tuesday, October 26th. Raymond James set a $136.00 price objective on Royal Gold and gave the company an "outperform" rating in a report on Thursday, November 4th. BMO Capital Markets lifted their price objective on Royal Gold from $138.00 to $145.00 and gave the company a "market perform" rating in a report on Friday, August 13th. Finally, National Bank Financial lowered their price objective on Royal Gold from C$160.00 to C$155.00 and set a "sector perform" rating on the stock in a report on Friday, September 10th. Six research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, Royal Gold has an average rating of "Hold" and an average price target of $136.03.

NASDAQ RGLD opened at $105.43 on Monday. The company has a quick ratio of 3.65, a current ratio of 3.85 and a debt-to-equity ratio of 0.04. Royal Gold has a 52-week low of $92.01 and a 52-week high of $129.69. The business's 50-day moving average price is $101.26 and its 200 day moving average price is $111.48. The firm has a market cap of $6.92 billion, a P/E ratio of 26.10, a P/E/G ratio of 2.67 and a beta of 0.64. Read more …

 

AbbVie (NYSE:ABBV) was upgraded by investment analysts at Societe Generale from a "hold" rating to a "buy" rating in a report issued on Tuesday, PriceTargets.com reports.

Several other analysts also recently weighed in on ABBV. Mizuho lifted their price target on shares of AbbVie from $128.00 to $131.00 and gave the company a "buy" rating in a research note on Monday, August 2nd. Argus increased their price target on AbbVie from $130.00 to $140.00 and gave the stock a "buy" rating in a research report on Thursday, August 5th. Truist Securities started coverage on AbbVie in a report on Tuesday, July 27th. They issued a "buy" rating and a $117.00 price objective for the company. Cowen upped their price objective on shares of AbbVie from $120.00 to $130.00 and gave the stock an "outperform" rating in a research note on Monday, August 23rd. Finally, Morgan Stanley raised their target price on shares of AbbVie from $116.00 to $124.00 and gave the company an "overweight" rating in a research report on Monday, November 1st. One equities research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Buy" and an average price target of $127.17.

ABBV stock traded up $3.23 during midday trading on Tuesday, reaching $118.88. The company's stock had a trading volume of 8,594,465 shares, compared to its average volume of 6,838,689. The company has a debt-to-equity ratio of 5.45, a quick ratio of 0.91 and a current ratio of 1.01. The stock has a fifty day simple moving average of $111.39 and a two-hundred day simple moving average of $113.87. AbbVie has a 1 year low of $101.55 and a 1 year high of $121.53. The firm has a market capitalization of $210.08 billion, a price-to-earnings ratio of 28.30, a PEG ratio of 2.46 and a beta of 0.83. Read more …

 

 

Best Buy (NYSE:BBY) was upgraded by research analysts at Bank of America to a “buy” rating in a research report issued on Wednesday, The Fly reports.

Several other equities research analysts also recently weighed in on BBY. Wedbush raised Best Buy to a “buy” rating in a research report on Wednesday, August 25th. DA Davidson raised Best Buy to a “buy” rating in a research report on Wednesday, August 25th. Zacks Investment Research reaffirmed a “buy” rating on shares of Best Buy in a research report on Friday, September 10th. Jefferies Financial Group increased their price target on Best Buy from $136.00 to $145.00 and gave the stock a “buy” rating in a research report on Wednesday, August 25th. Finally, Citigroup restated a “buy” rating on shares of Best Buy in a research report on Wednesday. One research analyst has rated the stock with a sell rating, five have issued a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Buy” and an average target price of $128.31. Read more …

 

Bank of Nova Scotia (NYSE:BNS) (TSE:BNS) was upgraded by equities researchers at Canaccord Genuity from a “hold” rating to a “buy” rating in a research note issued on Wednesday, The Fly reports.

Other equities analysts have also issued research reports about the stock. National Bank Financial increased their target price on shares of Bank of Nova Scotia from $84.00 to $86.00 and gave the company a “sector perform” rating in a report on Wednesday, August 25th. TD Securities reduced their target price on shares of Bank of Nova Scotia from C$90.00 to C$87.00 and set a “buy” rating on the stock in a report on Wednesday, August 25th. Veritas Investment Research reaffirmed a “buy” rating on shares of Bank of Nova Scotia in a report on Friday, November 12th. Royal Bank of Canada increased their target price on shares of Bank of Nova Scotia from C$86.00 to C$89.00 and gave the company an “outperform” rating in a report on Wednesday, August 25th. Finally, Zacks Investment Research cut shares of Bank of Nova Scotia from a “buy” rating to a “hold” rating in a research report on Tuesday. Four research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to MarketBeat.com, Bank of Nova Scotia presently has an average rating of “Buy” and an average target price of $86.43. Read more …

 

Chevron (NYSE:CVX) was upgraded by stock analysts at Royal Bank of Canada from a "sector perform" rating to an "outperform" rating in a research note issued on Wednesday, The Fly reports.

A number of other research firms also recently issued reports on CVX. TheStreet upgraded shares of Chevron from a "c" rating to a "b-" rating in a research report on Friday, July 30th. Zacks Investment Research downgraded shares of Chevron from a "buy" rating to a "hold" rating and set a $100.00 target price for the company. in a research report on Tuesday, September 21st. Wells Fargo & Company increased their target price on shares of Chevron from $109.00 to $115.00 and gave the stock an "equal weight" rating in a research report on Monday, November 1st. DZ Bank downgraded shares of Chevron from a "buy" rating to a "hold" rating and set a $110.00 target price for the company. in a research report on Wednesday, August 4th. Finally, Morgan Stanley raised their price target on shares of Chevron from $149.00 to $155.00 and gave the company an "overweight" rating in a report on Friday, November 19th. Ten research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Buy" and an average target price of $120.65.

Chevron stock opened at $116.30 on Wednesday. The company has a 50 day moving average price of $108.83 and a 200 day moving average price of $104.82. Chevron has a 52 week low of $83.53 and a 52 week high of $118.08. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.03 and a current ratio of 1.28. The firm has a market capitalization of $224.19 billion, a price-to-earnings ratio of 22.45, a P/E/G ratio of 2.42 and a beta of 1.30. Read more …

 

 

 

Downgrades:

 

AstraZeneca (NASDAQ:AZN) was downgraded by stock analysts at Bryan, Garnier & Co to a “buy” rating in a research note issued to investors on Monday, The Fly reports.

Several other brokerages have also issued reports on AZN. SVB Leerink lifted their price target on AstraZeneca from $71.00 to $73.00 and gave the company an “outperform” rating in a research note on Monday, September 27th. JPMorgan Chase & Co. assumed coverage on AstraZeneca in a research note on Thursday, August 12th. They issued an “overweight” rating on the stock. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of AstraZeneca in a research note on Monday, October 11th. UBS Group restated a “buy” rating on shares of AstraZeneca in a research report on Tuesday, October 19th. Finally, Morgan Stanley restated an “overweight” rating on shares of AstraZeneca in a research report on Friday, September 17th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Buy” and an average price target of $124.00. Read more …

 

Pembina Pipeline (NYSE:PBA) (TSE:PPL) was downgraded by equities researchers at CIBC from an "outperform" rating to a "neutral" rating in a note issued to investors on Monday, The Fly reports.

A number of other analysts also recently commented on the company. TD Securities upped their price objective on Pembina Pipeline from C$43.00 to C$45.00 and gave the stock a "buy" rating in a report on Monday, November 8th. Royal Bank of Canada upped their price objective on Pembina Pipeline from C$42.00 to C$48.00 and gave the stock an "outperform" rating in a report on Monday, August 9th. Scotiabank upped their price objective on Pembina Pipeline from C$42.00 to C$43.00 and gave the stock a "sector perform" rating in a report on Friday, November 5th. Credit Suisse Group initiated coverage on Pembina Pipeline in a report on Wednesday, August 18th. They set a "neutral" rating for the company. Finally, BMO Capital Markets initiated coverage on shares of Pembina Pipeline in a research report on Wednesday, July 28th. They set a "market perform" rating for the company. One analyst has rated the stock with a sell rating, ten have given a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $40.40.

Shares of NYSE:PBA traded down $1.03 during trading on Monday, hitting $31.87. 81,796 shares of the stock were exchanged, compared to its average volume of 1,108,605. The company has a fifty day moving average price of $32.77 and a two-hundred day moving average price of $32.19. The company has a market cap of $17.54 billion, a PE ratio of -132.79, a P/E/G ratio of 5.35 and a beta of 1.43. The company has a current ratio of 0.54, a quick ratio of 0.52 and a debt-to-equity ratio of 0.84. Pembina Pipeline has a 12-month low of $23.48 and a 12-month high of $34.73. Read more …

 

Royal Bank of Canada (NYSE:RY) (TSE:RY) was downgraded by investment analysts at Bank of America from a “neutral” rating to an “underperform” rating in a research note issued to investors on Monday, The Fly reports.

Several other analysts have also recently weighed in on RY. Desjardins lifted their price objective on shares of Royal Bank of Canada from C$138.00 to C$141.00 and gave the stock a “buy” rating in a research note on Friday, August 27th. Zacks Investment Research cut shares of Royal Bank of Canada from a “buy” rating to a “hold” rating in a research note on Saturday, November 13th. Scotiabank lifted their price objective on shares of Royal Bank of Canada from C$144.00 to C$148.00 in a research note on Tuesday, August 17th. Fundamental Research lifted their price objective on shares of Royal Bank of Canada from $127.27 to $143.76 and gave the stock a “buy” rating in a research note on Wednesday, September 1st. Finally, Credit Suisse Group boosted their target price on shares of Royal Bank of Canada from C$135.00 to C$140.00 and gave the company an “outperform” rating in a research report on Thursday, August 26th. One research analyst has rated the stock with a sell rating, three have given a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $134.48. Read more …

 

 

Ventas (NYSE:VTR) was downgraded by equities researchers at Sumitomo Mitsui Financial Group from an "outperform" rating to a "neutral" rating in a report issued on Monday, Price Targets.com reports. They currently have a $55.00 price objective on the real estate investment trust's stock. Sumitomo Mitsui Financial Group's price target indicates a potential upside of 7.11% from the stock's current price.

Other equities analysts also recently issued reports about the company. Capital One Financial restated an "equal weight" rating on shares of Ventas in a report on Friday, November 5th. Raymond James upgraded Ventas from an "outperform" rating to a "strong-buy" rating and increased their target price for the company from $65.00 to $67.00 in a research note on Thursday, September 23rd. BMO Capital Markets upgraded Ventas from an "underperform" rating to a "market perform" rating and set a $60.00 target price for the company in a research note on Thursday, August 26th. Deutsche Bank Aktiengesellschaft upgraded Ventas from a "hold" rating to a "buy" rating and increased their target price for the company from $61.00 to $66.00 in a research note on Tuesday, September 7th. Finally, Morgan Stanley started coverage on Ventas in a research note on Monday, October 4th. They issued an "equal weight" rating and a $60.00 target price for the company. Eight analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Buy" and a consensus target price of $59.24.

Ventas stock opened at $51.35 on Monday. The stock's 50-day moving average is $55.15 and its 200-day moving average is $56.34. The company has a market cap of $20.50 billion, a price-to-earnings ratio of 96.89, a price-to-earnings-growth ratio of 4.94 and a beta of 1.17. The company has a debt-to-equity ratio of 1.08, a current ratio of 0.59 and a quick ratio of 0.71. Ventas has a 12 month low of $45.40 and a 12 month high of $61.09. Read more …

 

National Bank of Canada (TSE:NA) was downgraded by research analysts at Scotiabank to a “hold” rating in a report issued on Tuesday, TipRanks reports. They presently have a C$113.00 target price on the financial services provider’s stock. Scotiabank’s price target points to a potential upside of 7.38% from the company’s previous close.

NA has been the topic of several other reports. Canaccord Genuity boosted their target price on National Bank of Canada from C$101.00 to C$103.50 and gave the stock a “hold” rating in a report on Thursday, August 26th. Barclays cut National Bank of Canada to a “sell” rating and set a C$100.00 target price on the stock. in a report on Monday, November 15th. BMO Capital Markets boosted their target price on National Bank of Canada from C$101.00 to C$104.00 and gave the stock an “outperform” rating in a report on Thursday, August 26th. Credit Suisse Group restated a “neutral” rating on shares of National Bank of Canada in a report on Thursday, September 2nd. Finally, Cormark lifted their price target on shares of National Bank of Canada from C$109.00 to C$112.00 and gave the company a “buy” rating in a research report on Thursday, August 26th. One analyst has rated the stock with a sell rating, six have issued a hold rating and four have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of C$100.23. Read more …

 

Most Significant Insider Trades: Week of August 23, 2021

 

Disposals:

 

Eaton Co. plc (NYSE:ETN) insider Nandakumar Cheruvatath sold 7,529 shares of the business’s stock in a transaction dated Thursday, August 19th. The stock was sold at an average price of $168.00, for a total transaction of $1,264,872.00. The transaction was disclosed in a filing with the SEC, which is available through this link.

Nandakumar Cheruvatath also recently made the following trade(s):

On Wednesday, June 2nd, Nandakumar Cheruvatath sold 6,400 shares of Eaton stock. The stock was sold at an average price of $146.56, for a total transaction of $937,984.00.

ETN stock traded up $1.38 during midday trading on Monday, reaching $168.84. 1,398,200 shares of the company’s stock traded hands, compared to its average volume of 1,971,036. Eaton Co. plc has a 52-week low of $96.24 and a 52-week high of $169.64. The company has a market cap of $67.30 billion, a PE ratio of 36.00, a P/E/G ratio of 2.22 and a beta of 1.14. The company has a current ratio of 1.10, a quick ratio of 0.80 and a debt-to-equity ratio of 0.56. The stock’s 50-day moving average is $154.87. Read more …

 

eBay Inc. (NASDAQ:EBAY) Director Robert Holmes Swan sold 40,000 shares of the firm’s stock in a transaction on Thursday, August 19th. The shares were sold at an average price of $73.15, for a total transaction of $2,926,000.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

EBAY stock traded down $0.16 during mid-day trading on Monday, hitting $73.20. The company had a trading volume of 5,036,311 shares, compared to its average volume of 7,620,209. The stock has a market cap of $47.58 billion, a price-to-earnings ratio of 3.91, a PEG ratio of 2.12 and a beta of 1.09. The company has a debt-to-equity ratio of 0.64, a quick ratio of 3.96 and a current ratio of 3.96. eBay Inc. has a 12 month low of $45.36 and a 12 month high of $76.55. The firm’s fifty day moving average is $69.12. Read more …

 

The Wendy’s Company (NASDAQ:WEN) Director Matthew H. Peltz sold 161,922 shares of the business’s stock in a transaction that occurred on Wednesday, August 25th. The stock was sold at an average price of $23.49, for a total transaction of $3,803,547.78.  He also sold 382,403 shares of the stock in a transaction that occurred on Friday, August 27th. The stock was sold at an average price of $23.38, for a total value of $8,940,582.14. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Shares of The Wendy’s stock traded up $0.16 on Friday, reaching $23.34. The company’s stock had a trading volume of 1,998,691 shares, compared to its average volume of 3,691,044. The company has a market cap of $5.20 billion, a P/E ratio of 28.81, a price-to-earnings-growth ratio of 3.22 and a beta of 0.94. The company’s fifty day moving average price is $23.02. The Wendy’s Company has a 52 week low of $18.86 and a 52 week high of $29.46. The company has a quick ratio of 2.24, a current ratio of 2.25 and a debt-to-equity ratio of 5.08. Read more …

 

 

NVIDIA Co. (NASDAQ:NVDA) Director Persis Drell sold 10,000 shares of NVIDIA stock in a transaction dated Friday, August 20th. The stock was sold at an average price of $203.41, for a total value of $2,034,100.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Persis Drell also recently made the following trade(s):

On Monday, June 14th, Persis Drell sold 800 shares of NVIDIA stock. The stock was sold at an average price of $716.47, for a total value of $573,176.00.

NASDAQ:NVDA traded down $1.65 during trading hours on Tuesday, reaching $217.93. The company’s stock had a trading volume of 29,542,888 shares, compared to its average volume of 35,407,160. The firm has a 50 day simple moving average of $196.49. The stock has a market cap of $543.08 billion, a P/E ratio of 77.63, a P/E/G ratio of 3.55 and a beta of 1.35. The company has a quick ratio of 5.33, a current ratio of 5.80 and a debt-to-equity ratio of 0.52. NVIDIA Co. has a 12 month low of $115.67 and a 12 month high of $219.97. Read more …

AbbVie- A High Dividend Opportunity

 

AbbVie (ABBV) is the seventh-largest pharmaceutical company on the globe in terms of revenue; the company is also a Dividend Aristocrat, having nearly a half-century of dividend growth to its credit.

 

Since splitting from Abbott Labs (ABT) in 2013, AbbVie has grown revenue by nearly 2.5 times, from $18.8 billion post-spin-off to nearly $46 billion this last fiscal year. Much of the growth was fueled by the blockbuster drug, Humira.

 

Therein lies the problem with an investment in the stock. As the number-one selling drug in 2020, Humira sales constituted the lion’s share of the firm’s revenue.

 

Combine that outsized contribution with the fact that Humira goes off-patent in the U.S. in 2023, and there is cause for concern.

 

At the same time, however, there are reasons to believe AbbVie is well-positioned for a future without Humira. The 2015 deal to acquire Pharmacyclics added blockbuster drug Imbruvica to the company’s portfolio.

 

A second acquisition last May brought Allergan under the firm’s banner. With that deal, the company added over 120 additional products that, collectively, generated $16 billion in sales in 2019.

 

Much of the growth in AbbVie’s revenue, an increase from less than $33.3 billion in FY19 to approximately $45.8 billion in FY20, can be attributed to the addition of Allergan product lines.

 

 

Perhaps the most important of those is Botox. In 2019, it recorded nearly $2.7 billion in sales. Like Imbruvica, Botox has a fairly strong growth runway. Allergan also added 60 development programs to AbbVie’s pipeline.

 

Continue reading …